Record overview
Status and phase
Status: COMPLETED
Phase: PHASE2
Sponsor: Hoffmann-La Roche
Condition: Non-Squamous Non-Small Cell Lung Cancer
NCT01378962
A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (TRIGGER)
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.